Rifadin

In some countries, this medicine may only be approved for veterinary use.

In the US, Rifadin (rifampin systemic) is a member of the drug class rifamycin derivatives and is used to treat Endocarditis, Haemophilus influenzae Prophylaxis, Legionella Pneumonia, Leprosy, Leprosy - Borderline, Leprosy - Tuberculoid, Meningitis, Meningococcal Meningitis Prophylaxis, Nasal Carriage of Staphylococcus aureus, Tuberculosis - Active, Tuberculosis - Latent and Tuberculosis - Prophylaxis.

US matches:

• Rifadin


• Rifadin IV


• Rifadin IV Intravenous

UK matches:

• Rifadin 150mg Capsules (SPC)
• Rifadin 300mg Capsules (SPC)
• Rifadin For Infusion 600mg (SPC)
• Rifadin syrup 100mg/5ml (SPC)

Ingredient matches for Rifadin

Rifampicin

Rifampicin is reported as an ingredient of Rifadin in the following countries:

• Argentina


• Australia


• Canada


• Ethiopia


• Ghana


• Greece


• Hong Kong


• Ireland


• Italy


• Japan


• Kenya


• Malta


• Mexico


• Netherlands


• New Zealand


• Nigeria


• Oman


• Portugal


• Sweden


• Taiwan


• Thailand


• Turkey


• Uganda


• United Kingdom


• United States


• Zimbabwe

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.